INS and type 1 diabetes mellitus: In another phase 2 clinical trial (NCT01561508), GABA, along with insulin, was being tested for the new-onset T1D in children, aiming to help in the insulin production and decrease glucagon release and inflammation, but the clinical trial was withdrawn and has no results.